Moreover, we used RSL3, a known inducer of ferroptosis, to promote GPX4 degradation and found that the reduction in GPX4 levels in OTULIN-knockdown osteosarcoma cells was further accelerated by treatment with RSL3 together with CHX (Fig. 7e). Here, GPX4 is linked to osteosarcoma.